What companies are LABD's competitors?

Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does LABD compare to its peers?

The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does LABD operate in?

Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LABD

Direxion Daily S&P Biotech Bear 3X ETF

AMEX·Asset Management, Leveraged · Financial Services

$8.77$0.31+3.61%

After hours·$8.77+0.06%

Market cap$20.04M·Market closed·Jul 24 7:59 PM UTC

Frequently Asked Questions About LABD

What companies are LABD's competitors?: Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LABD compare to its peers?: The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LABD operate in?: Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LABD

Direxion Daily S&P Biotech Bear 3X ETF

AMEX·Asset Management, Leveraged · Financial Services

$8.77$0.31+3.61%

After hours·$8.77+0.06%

Market cap$20.04M·Market closed·Jul 24 7:59 PM UTC

Peers


GLL	ProShares - UltraShort Gold	$26.48	$128.1M
BITI	ProShares Short Bitcoin ETF	$24.93	$103.7M
TSLS	Direxion Daily TSLA Bear 1X ETF	$65.05	$75.2M
SARK	Tradr 1X Short Innovation Daily ETF	$29.33	$73.9M
DIG	ProShares - Ultra Energy	$61.02	$67.9M
INDL	Direxion Daily MSCI India Bull 2X ETF	$41.80	$55.6M
DRN	Direxion Daily Real Estate Bull 3X ETF	$11.10	$45.6M
MAGX	Roundhill Investments - Daily 2X Long Magnificent Seven ETF	$48.66	$43.3M
DRIP	Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF	$40.92	$42.7M
JDST	Direxion Daily Junior Gold Miners Index Bear 2X ETF	$40.50	$30.6M

Frequently Asked Questions About LABD

What companies are LABD's competitors?: Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LABD compare to its peers?: The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LABD operate in?: Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.